InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,865.29
(
-1.41%
)
US TECH 100
19,844.40
(
-2.47%
)
Dow Jones
43,403.56
(
-0.79%
)
Brent Oil
70.91
(
-1.81%
)
Bitcoin
89,631.30
(
2.62%
)
Post# of 253617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120727
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Dr Bill post# 39594

Wednesday, 12/20/2006 1:03:44 PM

Wednesday, December 20, 2006 1:03:44 PM

Post# of 253617
Question for RPRX longs: Why is Androxal being compared to AndroGel instead of being compared to Testim?

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_...

>>
“Five published clinical studies were reviewed. Testim 50 mg showed clear pharmacokinetic differences from AndroGel 1% testosterone gel 50 mg, with increases of 30% (90% CI, 8%-57%) and 47% (90% CI, 20%-79%) versus AndroGel, respectively, in AUC(0-24h) for total serum testosterone and free testosterone.”
<<

Also see this 2004 press release:
http://www.bentleypharm.com/documents/pr-111904.pdf

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up